"AI is not a bubble," declared Stephanie Link, Hightower Advisors' Chief Investment Strategist and Portfolio Manager, during a recent appearance on CNBC's 'Squawk Box'. Her assertion cut through the pervasive market anxiety that often accompanies transformative technological surges, offering a grounded perspective on artificial intelligence's economic underpinnings. Link, speaking with Andrew Sorkin ahead of the opening bell on Monday, dissected current market trends, pivoting from specific stock news to a broader commentary on the enduring and tangible impact of AI across various sectors.
The interview initially touched upon the disappointing news regarding Novo Nordisk's Alzheimer's drug, which saw the stock dip nearly 10% in extended hours. Link acknowledged the negative sentiment but suggested that the market had not heavily factored in the drug's potential success into existing models, indicating a degree of insulated risk. Her focus quickly shifted to the more robust prospects of the company's Wegovy pill launch and upcoming guidance, framing Novo Nordisk as a "battleground stock" where bulls would concentrate on existing revenue streams rather than speculative drug pipelines. This brief detour into pharmaceutical volatility set the stage for a deeper dive into technology, specifically the burgeoning AI landscape.
